Primary |
Drug Use For Unknown Indication |
40.2% |
Product Used For Unknown Indication |
9.6% |
Pain |
7.6% |
Back Pain |
4.7% |
Pyrexia |
4.2% |
Hypertension |
3.9% |
Arthritis |
3.7% |
Osteoarthritis |
3.1% |
Toothache |
2.8% |
Juvenile Arthritis |
2.6% |
Headache |
2.4% |
Depression |
2.3% |
Arthralgia |
2.0% |
Systemic Lupus Erythematosus |
2.0% |
Pain In Extremity |
1.8% |
Completed Suicide |
1.6% |
Musculoskeletal Pain |
1.6% |
Fibromyalgia |
1.3% |
Migraine |
1.3% |
Patent Ductus Arteriosus |
1.3% |
|
Death |
18.5% |
Renal Failure Acute |
13.9% |
Vomiting |
7.3% |
Gastrointestinal Haemorrhage |
6.6% |
Melaena |
4.6% |
Respiratory Depression |
4.6% |
Vision Blurred |
4.6% |
Neurodevelopmental Disorder |
4.0% |
Unresponsive To Stimuli |
4.0% |
Drug Toxicity |
3.3% |
Dyspnoea |
3.3% |
Gastric Haemorrhage |
3.3% |
Weight Decreased |
3.3% |
Anaphylactic Reaction |
2.6% |
Drug Ineffective |
2.6% |
Gastric Ulcer |
2.6% |
Haematemesis |
2.6% |
Haemorrhage Intracranial |
2.6% |
Overdose |
2.6% |
Renal Disorder |
2.6% |
|
Secondary |
Drug Use For Unknown Indication |
24.8% |
Osteoarthritis |
16.6% |
Rheumatoid Arthritis |
14.2% |
Product Used For Unknown Indication |
7.6% |
Hypertension |
4.7% |
Pain |
4.7% |
Bronchitis |
4.3% |
Spinal Osteoarthritis |
4.0% |
Arthritis |
3.5% |
Headache |
2.5% |
Back Pain |
2.1% |
Pyrexia |
1.8% |
Anxiety |
1.6% |
Arthralgia |
1.3% |
Atrial Fibrillation |
1.3% |
Pain In Extremity |
1.3% |
Diabetes Mellitus |
0.9% |
Medical Diet |
0.9% |
Psoriasis |
0.9% |
Depression |
0.9% |
|
Weight Decreased |
10.7% |
Vomiting |
10.2% |
Completed Suicide |
9.0% |
Renal Failure Acute |
7.3% |
Death |
6.8% |
Stomach Discomfort |
5.1% |
Suicide Attempt |
5.1% |
Tachycardia |
5.1% |
Toxic Epidermal Necrolysis |
4.5% |
Cardio-respiratory Arrest |
4.0% |
Perforated Ulcer |
4.0% |
Urticaria |
4.0% |
Blood Creatinine Increased |
3.4% |
Pyrexia |
3.4% |
Tubulointerstitial Nephritis |
3.4% |
Urinary Tract Infection |
3.4% |
Vision Blurred |
3.4% |
Toxic Skin Eruption |
2.8% |
Malaise |
2.3% |
Oedema Peripheral |
2.3% |
|
Concomitant |
Drug Use For Unknown Indication |
36.4% |
Pain |
12.2% |
Rheumatoid Arthritis |
6.8% |
Hypertension |
5.4% |
Depression |
5.2% |
Product Used For Unknown Indication |
4.7% |
Prophylaxis |
3.2% |
Multiple Sclerosis |
3.1% |
Anxiety |
2.5% |
Back Pain |
2.2% |
Hiv Infection |
2.2% |
Non-small Cell Lung Cancer |
2.1% |
Headache |
2.0% |
Parkinson's Disease |
1.9% |
Insomnia |
1.8% |
Breast Cancer |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Type 2 Diabetes Mellitus |
1.7% |
Asthma |
1.6% |
Diabetes Mellitus |
1.6% |
|
Vomiting |
13.9% |
Weight Decreased |
11.7% |
Weight Increased |
7.9% |
Pain |
7.0% |
Myocardial Infarction |
6.0% |
Flushing |
5.4% |
Pruritus |
4.7% |
Vision Blurred |
4.1% |
Ventricular Septal Defect |
3.8% |
Headache |
3.5% |
Nausea |
3.5% |
Rash |
3.5% |
Death |
3.2% |
Dyspnoea |
3.2% |
Pyrexia |
3.2% |
Seroma |
3.2% |
Suicide Attempt |
3.2% |
White Blood Cell Count Decreased |
3.2% |
Wrong Technique In Drug Usage Process |
3.2% |
Renal Failure Acute |
2.8% |
|
Interacting |
Drug Use For Unknown Indication |
33.9% |
Product Used For Unknown Indication |
22.0% |
Hypertrophic Cardiomyopathy |
6.8% |
Hypertension |
5.1% |
Systemic Lupus Erythematosus |
5.1% |
Back Pain |
3.4% |
Musculoskeletal Pain |
3.4% |
Anxiety |
1.7% |
Back Disorder |
1.7% |
Cardiac Failure |
1.7% |
Coronary Artery Disease |
1.7% |
Epilepsy |
1.7% |
Febrile Infection |
1.7% |
Gastrointestinal Stromal Tumour |
1.7% |
Headache |
1.7% |
Insomnia |
1.7% |
Pain |
1.7% |
Pruritus Genital |
1.7% |
Smoking Cessation Therapy |
1.7% |
|
Thrombocytopenia |
30.8% |
Renal Failure Acute |
23.1% |
Hyponatraemia |
7.7% |
Somnolence |
7.7% |
Systemic Lupus Erythematosus |
7.7% |
Tendonitis |
7.7% |
Tremor |
7.7% |
Von Willebrand's Disease |
7.7% |
|